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Abstract
Background: Accurate and prompt diagnosis of HIV and syphilis simultaneously has reinforcing effect on their
control program because of their prevalent co-infection. Availability of a simple user-friendly two-pronged and
affordable detection tools brings down the cost of health care. They are important in the antenatal clinics, with
added opportunity for intervention and prevention of mother to child transmission. In cooperation with rapid test
kit manufacturers, SD Bioline, NPHL and NCASC, an evaluation of commercially available HIV/syphilis Duo rapid test
kit (SD Bioline) to assess its performance and operational characteristics was done in the present study.
Method: A prospective laboratory-based cross sectional study was conducted at a large Women’s Hospital. Ten
thousand pregnant women, visiting the Hospital for antenatal care or for delivery, were enrolled in study. Tests
were performed by the SD Bioline HIV/Syphilis Duo kit as well as national algorithm for HIV and syphilis diagnosis
which were considered gold standard. Sensitivity, Specificity, positive predictive value and negative predictive value
along with kappa coefficient were calculated for the kit under evaluation.
Result: The sensitivity, specificity, Negative predictive value and Positive predictive value of the kit for HIV diagnosis
were 100 % (95 % CI 83.18–100 %, 99.96–100 %, 83.18–100 %, and 99.96–100 %, respectively). Kappa value was
found to be 1.0. Out of total cases, results of 9985 (99.85 %) cases were concordant with National algorithm for
syphilis diagnosis. Thirteen (0.13 %) cases were found false positive while two were false negative. The sensitivity of
the kit for syphilis diagnosis was found to be 95.45 % (95 % CI 84.86–98.74 %) and specificity was 99.87 % (95 % CI;
99.78–99.92 %). Positive predictive value was 76.36 % (95 % CI; 63.65–85.63 %) and Negative predictive value was
99.89 % (95 % CI; 99.39–99.99 %). Kappa value was found to be 0.85.
Conclusion: The performance characteristics of SD Bioline HIV/Syphilis duo kit were found almost concordant with
the kits being used for HIV and Syphilis diagnosis separately. Its implementation in antenatal clinics/VCTs could be
an added opportunity for simultaneous diagnosis of HIV and syphilis.
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Background
Accurate and prompt diagnosis of HIV and syphilis is crit-
ical to disease control especially during the antenatal
period with an additional opportunity for treatment and
prevention of adverse effects of these disorders on the
offspring.
Review of literature shows that co-infection with syphilis
can increase the transmission of HIV by both increasing
viral shedding through open ulcers [1, 2] and by increasing
patient viral load [3, 4]. Simple user-friendly two-pronged
and affordable detection tools could save lives and reduce
overall costs borne by patients and health systems.
Rapid, accessible tests for simultaneous screening for
HIV as well as syphilis are available on the market, but
reliable information about their efficiency and dependabil-
ity in quality or performance is coming up only gradually.
Reliable evaluation reports of commercially available rapid
diagnostic tests for tuberculosis [5] has been published
but for syphilis and HIV large sized study reports of dual
test kits are yet awaited.
Screening for HIV and syphilis is a basic routine test be-
ing an inseparable part of any antenatal check-up protocol
and is also endorsed in the American Congress of Obste-
tricians and Gynecologists (ACOG) Guidelines for Peri-
natal Care [6]. Simultaneous screening for both these
disorders would be cost-effective as well as time-saving.
The current situation in Nepal entails the practice of test-
ing separately for syphilis by screening by RPR test and
confirmation by TPHA method and testing for HIV by fol-
lowing the National algorithm for HIV rapid diagnosis [7].
So, a rapid dual testing kit would meet the long felt
need in the field as well as in the hospital settings.
Hence, in cooperation with rapid test kit manufacturers,
SD Bioline/NPHL, we undertook an evaluation of com-
mercially available HIV/syphilis Duo rapid test kit (SD
Bioline) to assess its performance, reproducibility and
operational characteristics and to identify its utility as a
reliable screening tool.
Methods
The study was carried out with the cases enrolled at the ante-
natal clinic of Paropkar Maternity and Women’s Hospital
(PMWH), Kathmandu, Nepal with the test-confirmation and
backup-reference laboratory testing supported by the National
Public Health Laboratory, Teku, Kathmandu, Nepal during the
study period between July, 2014 and December, 2014.
Paropkar Maternity and Women’s Hospital is the largest
maternity and gynecological hospital of the country serv-
ing population of the local embankment area communities
as well as a large number of referral cases from all over
the country. The National Public Health Laboratory is the
apex laboratory institution of the country serving as a gen-
eral and reference laboratory especially for investigations
of public health importance.
All women attending the antenatal clinic of PMWH
were enrolled in the study. This included all cases on
their first visit to the ANC clinic as well as those on sub-
sequent visits or for delivery, without being previously
screened for HIV and/or syphilis. Women who were
diagnostically confirmed cases or those already on thera-
peutic intervention with presumed diagnosis fell into the
exclusion criteria. Informed written consent were taken
in local language from all participants and ethical ap-
proval obtained from the ethical committee of the Nepal
Health Research Council (NHRC).
Sample collection: Two types of samples were col-
lected depending upon suitability for the tests and pa-
tient convenience: [1] blood collection by venipuncture
for serum collection and [2] capillary blood collection by
finger-prick method. All procedures for specimen collec-
tion were performed by laboratory personnels taking all
biosafety precautions.
Test kit: SD BIOLINE HIV/syphilis Duo test kits
(Standard Diagnostic Inc., Korea) were obtained for the
evaluation study.
Procedural steps (Fig. 1)
All the collected samples were tested using SD Bioline
HIV/Syphilis duo test kit and after interpreting the test
results as per manufacturer’s guideline entered into the
records. In addition, all samples were simultaneously
tested by using national HIV testing algorithm [7] with a
combination of Determine HIV-1/2/O assay (Abbott
Laboratories, Abbott Park, IL), Uni-Gold Recombinant
HIV-1/2 (Trinity Biotech, Bray, Ireland) HIV 1/2 Stat-
Pak Ultra Fast (Chembio Diagnostic Systems, Medford,
NY). Testing for syphilis was done, first by RPR test by
using IMMUTREP RPR test kit (Omega Diagnostics
Scotland UK) and all test positive samples were re-
confirmed by TPHA method.
The used SD Bioline HIV/Syphilis duo test kits were
preserved for dispatching to SD Bioline Company, South
Korea.
Statistical analysis was carried out by using “openepi”
online software (http://openepi.com/Diagnostic Test/
DiagnosticTest.htm) for calculating sensitivity, specificity
and predictive values. Kappa values was calculated




Where, P0 was observed agreement and Pe was expected
agreement [8].
Result
Total number of samples collected were 10,000, out of
which 9,453 (94.53 %) were serum samples and 547 (5.47 %)
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were finger-prick whole blood samples as shown in Table 1.
Of the women attending the ante-natal clinic 57.71 % were
already in advanced pregnancy and near to delivery.
Testing for HIV
For HIV diagnosis, the sensitivity, specificity, negative
predictive value and positive predictive value of the test
kit were 100 % (95 % CI 83.18–100 %, 99.96–100 %,
83.18–100 %, and 99.96–100 %, respectively) and Kappa
value was found to be 1.0. Information about the num-
ber of sample tested and result obtained by given
methods are provided in Table 2.
Testing for syphilis
In the diagnosis of syphilis the test results of 9985
(99.85 %) samples using the test kit matched with that of
the Reference method. Thirteen (0.13 %) cases were false
positive and two were false negative. The sensitivity of
the test kit for syphilis diagnosis was 95.45 % (95 % CI:
84.86–98.74 %) and specificity was 99.87 % (95 % CI:
99.78–99.92 %). Positive predictive value was 76.36 %
(95 % CI; 63.65–85.63 %) and Negative predictive value
was 99.89 % (95 % CI: 99.39–99.99 %) and Kappa value
was found to be 0.85.
Of all samples tested for syphilis by the Reference
method (RPR method) using IMMUTREP RPR test kits,
44 (0.44 %) tested positive and of those tested using SD
Bioline HIV/Syphilis duo test kit 55 tests were positive.
Only 13 (23 %) tests were positive for syphilis in the
tests using HIV/Syphilis duo test kit and 2 (4 %) tested
positive for syphilis using IMMUTREP RPR test kit in
the whole series.
Discussion
An evaluation of the diagnostic performance of the SD
BIOLINE HIV/syphilis Duo test which is a two-pronged
screening kit for simultaneous detection of HIV and
Table 1 Sample size and sample characteristics (n = 10,000)
Sample collection method: Number of samples (%)
Venepuncture blood samples for
serum collection
9,453 (94.53 %)
Finger-prick whole blood samples 547 (5.47 %)
Total number of samples collected
by both methods
(9,453 + 547) = 10,000
Fig. 1 Procedural flow-chart
Table 2 Assay results of the SD BIOLINE HIV/syphilis Duo test
for dual detection of HIV and syphilis, Kathmandu, Nepal, 2014
RDT Infection RDT Result Reference methoda
Positive Negative Total
Using SD Bioline HIV/
Syphilis duo test kit
Syphilis Positive 42 13 55
Negative 2 9943 9945
Total 10,000
HIV Positive 19 0 19
Negative 0 9981 9981
Total 10,000
RDT rapid diagnostic test
aTested by using national HIV testing algorithm [7] with a combination of
Determine HIV-1/2/O assay (Abbott Laboratories, Abbott Park, IL), Uni-Gold
Recombinant HIV-1/2 (Trinity Biotech, Bray, Ireland) HIV 1/2 Stat-Pak Ultra Fast
(Chembio Diagnostic Systems, Medford, NY). Testing for syphilis was done, first
by RPR test by using IMMUTREP RPR test kit (Omega Diagnostics Scotland UK)
and all test positive samples were re-confirmed by TPHA method. (Thirteen
(0.13 %) cases in syphilis testing were found false positive while two were false
negative and in case of HIV all of 19 cases tested positive using SD Bioline
HIV/Syphilis duo test kit also tested positive by the reference method.)
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syphilis, has been undertaken in the present study. The
sensitivity and specificity of the kit in detecting HIV in-
fection were found to be remarkably high at 100 %.
These findings reiterate the results of earlier studies
done in other countries [9, 10]. Comparable results have
also been reported from the Southern Ethiopia, 2014
[11] study using the same test kit (shown in Table 3).
A rapid and sensitive tool for HIV testing has been a
long felt need among health workers in the fields and
the hospitals. Moreover, a two-pronged test kit designed
for simultaneous HIV and syphilis detection has been a
pressing need in the settings of the antenatal clinics and
as a screening test for prospective mothers. SD BIOLINE
HIV/syphilis Duo test has displayed many merits needed
for such a test. The consequences of false negative test
results in HIV testing of pregnant mothers have negative
impact on efforts for the prevention of mother to child
transmission of HIV infection (PMTCT). So, the results
of the present evaluation as a reliable screening test for
HIV without false negative test result need to be inter-
preted from these perspectives also. However, the SD
BIOLINE HIV/syphilis Duo test’s usefulness for screen-
ing HIV-infected cases missed by other tests must be
emphasized. Good screening tests do not replace the
confirmatory reference tests but by their performances
the consequences of false negative tests could be pre-
vented to a great extent.
In the present study, for the diagnosis of syphilis The SD
BIOLINE HIV/syphilis Duo test demonstrated a sensitivity
of 95.45 % (95 % CI: 84.86–98.74 %) and specificity was
99.87 % (95 % CI; 99.78–99.92 %). The positive predictive
value was 76.36 % (95 % CI; 63.65–85.63 %) and negative
predictive value was 99.89 % (95 % CI; 99.39–99.99 %) and
Kappa value was found to be 0.85. But these results have
to be interpreted in the light of the fact that the predictive
value of a test depends on the prevalence of a particular
infection, and that the test may also demonstrate different
performance elsewhere in lower prevalence regions. How-
ever, within the constraints of limited availability of diag-
nostic options in many resource-limited countries the SD
BIOLINE HIV/syphilis Duo test can be a strategic tool for
cost effective intervention in syphilis control through
antenatal screening and treatment of positive cases [12].
Simple and easy method of dual screening of HIV and
syphilis as observed in case of SD BIOLINE HIV/syphilis
Duo test enhances the accessibility of quality screening
service for most communities of the developing countries.
Besides, this presents an opportunity to be automatically
tested for syphilis for all those who get HIV testing with-
out having to wait for the results of a second test. This
may be an important step towards global elimination of
HIV and syphilis in the pregnant women and other
vulnerable risk groups.
Both HIV and syphilis being sexually transmitted dis-
eases share common mode of transmission because of
which simultaneous screening for both reinforces the
control strategy of one by the other. By using this dual
test kit as a point of care testing great impact can be ex-
pected in the control of both HIV and syphilis in the
economically disadvantaged communities as point of
care tests are strategic tools for the control and manage-
ment of STIs [13].
Conclusion
The performance characteristics of the SD Bioline HIV/
Syphilis Duo test kit were found almost concordant with
the reference kits currently being used for HIV and Syphilis
diagnosis in Nepal. The performance of the kit was ob-
served better for HIV diagnosis than for diagnosis of syph-
ilis. Use of SD Bioline HIV/Syphilis Duo test in antenatal
clinics/HTCs would meet the long felt need for a good
screening tool for their day to day use with opportunity for
simultaneous diagnosis of HIV and syphilis.
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Table 3 Comparison of results of Southern Ethiopia and
Kathmandu, Nepal studies
RDT Southern Ethiopia, 2014a Kathmandu, Nepal, 2014b
SD HIV/syphilis Duo Infection
% Sensitivity 95 % CI HIV 100 (98.5 to 100) 100 % (95 % CI: 83.18–100 %)
Syphilis 97.6 (92.4 to 99.6) 95.45 (95 % CI: 84.86–98.74 %)
% Specificity % CI HIV 99.5 (97.6 to 100) 100 % (95 % CI: 99.96–100 %)
Syphilis 96 (90.6 to 98.7) 99.87 (95 % CI: 99.78–99.92 %)
% PPV 95 % CI HIV 99.5 (97.6 to 100) 100 % (95 % CI: 83.18–100 %)
Syphilis 95.4 (89.3 to 98.5) 76.36 (95 % CI: 63.65–85.63 %)
% NPV 95 % CI HIV 100 (98.5 to 100) 100 % (95 % CI: 99.96–100 %)
Syphilis 98 (93.4 to 99.7) 99.89 (95 % CI; 99.39–99.99 %)
aSyphilis reference method, TPHA; HIV reference method, KHB/STAT-PAK/Unigold
algorithm + ELISA. KHB, Shenghai Kehua Bioengineering; NPV, negative predictive
value; PPV, positive predictive value; RDT, rapid diagnostic test. Ref: [11]
bReference method: Tested by using national HIV testing algorithm [7] with a
combination of Determine HIV-1/2/O assay (Abbott Laboratories, Abbott Park, IL),
Uni-Gold Recombinant HIV-1/2 (Trinity Biotech, Bray, Ireland) HIV 1/2 Stat-Pak Ultra
Fast (Chembio Diagnostic Systems, Medford, NY). Testing for syphilis was done, first
by RPR test by using IMMUTREP RPR test kit (Omega Diagnostics Scotland UK)
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